## HIMS: Hims & Hers Health, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 1.4% below STRENGTH zone (3.0-6.0%); PEG 5.23 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($34.00)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 1
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. HIMS CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against Hims & Hers Health, Inc. (HIMS)**
- Source: The National Law Review | 20251206T040218 | Neutral | Relevance: 98%
-  Kessler Topaz Meltzer & Check, LLP announced that a securities fraud class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS). The lawsuit alleges that Hims & Hers made materially false or misleading statements and failed to disclose that it was deceptively promoting illegitimate versions of Wegovy, which put patient safety at risk and jeopardized its collaboration with Novo Nordisk. Investors who purchased Hims & Hers securities between April 29, 2025, and June 23, 2025, are encouraged to contact the firm by August 25, 2025, to discuss potentially being appointed as a lead plaintiff.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 7 ($0.57M) |
| Sells | 25 ($13.26M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 67.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- JPMORGAN CHASE & CO: 16.2% (+1198.1%)
- Blackrock Inc.: 11.5% (+1.6%)
- Vanguard Group Inc: 8.9% (+4.5%)
- Capital World Invest: 8.6% (+1.2%)
- Farallon Capital Man: 4.9% (+30.8%)

### Key Risks

1. High beta (2.41) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Heavy insider selling: $13M sold (25 transactions in 90 days).
3. Valuation risk: PEG 5.2x with declining EPS estimates leaves no margin for error.
4. High short interest (36.7%, 2.2 days to cover): squeeze risk or crowded bearish bet.
5. Long-term trend broken: trading 14.9% below SMA200.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.8% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 5.23 signals overvaluation risk, limited margin of safety. Quality metrics strong (ROE 26%). Insider selling cluster ($13.3M in 90 days), potential headwind. Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $8.9B |
| Beta | 2.41 |
| 52W Range | $23.97 - $72.98 |
| Short Interest | 36.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.23 |
| Forward P/E | 59.4 |
| Current P/E | 81.9 |
| YoY Growth | 37.8% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -3.5% to 1.4% (+4.8% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.6pp (needs >3.0% for momentum thesis). MRS_5 at 1.8% confirms short-term momentum alignment. Outperforming sector by 4.8pp, stock-specific strength. Below SMA200 (0.85x), long-term trend not supportive. MACD histogram positive (0.82), confirming momentum. RSI neutral at 47.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 1.38% (CS: 69) | Neutral |
| RSI_14 | 47.3 | Neutral |
| MACD Histogram | 0.82 | Bullish |
| vs SMA20 | 1.042x | Above |
| vs SMA50 | 0.855x | Below |
| vs SMA200 | 0.851x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.12
- **Stop Loss:** $34.00 (13.1% risk)
- **Target:** $44.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 97
- **Position Value:** $3,794.64
- **Portfolio %:** 3.79%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-23 (Est: $0.05)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.10 | $0.06 | -41.0% |
| 2025Q2 | $0.16 | $0.17 | +3.2% |
| 2025Q1 | $0.12 | $0.20 | +65.0% |
| 2024Q4 | $0.11 | $0.11 | +0.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*